Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
274.93
+0.27 (0.10%)
At close: Aug 4, 2025, 4:00 PM
278.45
+3.52 (1.28%)
After-hours: Aug 4, 2025, 7:57 PM EDT

Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of $61.91 billion. The enterprise value is $83.53 billion.

Market Cap61.91B
Enterprise Value 83.53B

Important Dates

The last earnings date was Thursday, July 17, 2025, before market open.

Earnings Date Jul 17, 2025
Ex-Dividend Date Sep 10, 2025

Share Statistics

Elevance Health has 225.18 million shares outstanding. The number of shares has decreased by -2.43% in one year.

Current Share Class 225.18M
Shares Outstanding 225.18M
Shares Change (YoY) -2.43%
Shares Change (QoQ) -0.62%
Owned by Insiders (%) 0.12%
Owned by Institutions (%) 92.52%
Float 224.66M

Valuation Ratios

The trailing PE ratio is 11.76 and the forward PE ratio is 8.84. Elevance Health's PEG ratio is 1.71.

PE Ratio 11.76
Forward PE 8.84
PS Ratio 0.33
Forward PS 0.30
PB Ratio 1.41
P/TBV Ratio 16.02
P/FCF Ratio 11.60
P/OCF Ratio 9.59
PEG Ratio 1.71
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.81, with an EV/FCF ratio of 15.65.

EV / Earnings 15.58
EV / Sales 0.44
EV / EBITDA 8.81
EV / EBIT 9.56
EV / FCF 15.65

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.69.

Current Ratio 1.44
Quick Ratio 1.32
Debt / Equity 0.69
Debt / EBITDA 3.12
Debt / FCF 5.66
Interest Coverage 6.60

Financial Efficiency

Return on equity (ROE) is 12.42% and return on invested capital (ROIC) is 7.45%.

Return on Equity (ROE) 12.42%
Return on Assets (ROA) 4.65%
Return on Invested Capital (ROIC) 7.45%
Return on Capital Employed (ROCE) 11.19%
Revenue Per Employee $1.82M
Profits Per Employee $51,440
Employee Count104,200
Asset Turnover 1.61
Inventory Turnover n/a

Taxes

In the past 12 months, Elevance Health has paid $1.72 billion in taxes.

Income Tax 1.72B
Effective Tax Rate 24.32%

Stock Price Statistics

The stock price has decreased by -48.63% in the last 52 weeks. The beta is 0.59, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y) 0.59
52-Week Price Change -48.63%
50-Day Moving Average 348.63
200-Day Moving Average 391.85
Relative Strength Index (RSI) 30.71
Average Volume (20 Days) 3,252,747

Short Selling Information

The latest short interest is 2.72 million, so 1.21% of the outstanding shares have been sold short.

Short Interest 2.72M
Short Previous Month 2.50M
Short % of Shares Out 1.21%
Short % of Float 1.21%
Short Ratio (days to cover) 1.46

Income Statement

In the last 12 months, Elevance Health had revenue of $189.25 billion and earned $5.36 billion in profits. Earnings per share was $23.39.

Revenue189.25B
Gross Profit 50.79B
Operating Income 8.74B
Pretax Income n/a
Net Income 5.36B
EBITDA 9.49B
EBIT 8.74B
Earnings Per Share (EPS) $23.39
Full Income Statement

Balance Sheet

The company has $34.79 billion in cash and $30.19 billion in debt, giving a net cash position of -$21.63 billion or -$96.04 per share.

Cash & Cash Equivalents 34.79B
Total Debt 30.19B
Net Cash -21.63B
Net Cash Per Share -$96.04
Equity (Book Value) 43.85B
Book Value Per Share 194.46
Working Capital 19.49B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $6.45 billion and capital expenditures -$1.12 billion, giving a free cash flow of $5.34 billion.

Operating Cash Flow 6.45B
Capital Expenditures -1.12B
Free Cash Flow 5.34B
FCF Per Share $23.70
Full Cash Flow Statement

Margins

Gross margin is 26.84%, with operating and profit margins of 4.62% and 2.83%.

Gross Margin 26.84%
Operating Margin 4.62%
Pretax Margin 3.73%
Profit Margin 2.83%
EBITDA Margin 5.01%
EBIT Margin 4.62%
FCF Margin 2.82%

Dividends & Yields

This stock pays an annual dividend of $6.84, which amounts to a dividend yield of 2.49%.

Dividend Per Share $6.84
Dividend Yield 2.49%
Dividend Growth (YoY) 7.40%
Years of Dividend Growth 14
Payout Ratio 28.57%
Buyback Yield 2.43%
Shareholder Yield 4.91%
Earnings Yield 8.66%
FCF Yield 8.62%
Dividend Details

Analyst Forecast

The average price target for Elevance Health is $416.86, which is 51.62% higher than the current price. The consensus rating is "Buy".

Price Target $416.86
Price Target Difference 51.62%
Analyst Consensus Buy
Analyst Count 15
Revenue Growth Forecast (5Y) 8.99%
EPS Growth Forecast (5Y) 18.34%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.

Last Split Date Jun 1, 2005
Split Type Forward
Split Ratio 2:1

Scores

Altman Z-Score n/a
Piotroski F-Score 5